Benserazid

Benserazid
(IUPAC) ime
	(RS)-2-amino-3-hidroksi-N′-(2,3,4-trihidroksibenzil)propanhidrazid
Klinički podaci
AHFS/Drugs.com	Internacionalno ime leka
Identifikatori
CAS broj	14919-77-8
ATC kod	nije dodeljen
PubChem	2327
ChemSpider	2237
UNII	B66E5RK36Q
KEGG	D03082
ChEMBL	CHEMBL1096979
Hemijski podaci
Formula	C10H15N3O5
Mol. masa	257,243 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C10H15N3O5/c11-6(4-14)10(18)13-12-3-5-1-2-7(15)9(17)8(5)16/h1-2,6,12,14-17H,3-4,11H2,(H,13,18) ; Key: BNQDCRGUHNALGH-UHFFFAOYSA-N
Farmakokinetički podaci
Izlučivanje	Renalno i fekalno
Farmakoinformacioni podaci
Trudnoća	B3(AU)
Pravni status	POM (UK) (sa levodopom)

Benserazid (Serazid, Ro 4-4602) je periferno delujući inhibitor aromatična-L-aminokiselinske dekarboksilaze (AADC) ili DOPA dekarboksilaze, koji ne može da prođe kroz krvno-moždanu barijeru.^[6]

Indikacije[uredi | uredi kod]

Ovaj materijal se koristi u manadžmentu Parkinsonove bolesti u kombinaciji sa L-DOPA (levodopom) kao kobeneldopa (BAN), pod imenima Madopar u UK i Prolopa u Kanadi. Proizvodi ga preduzeće Roš. Benserazid nije odobren u SAD; karbidopa se koristi umesto njega za istu svrhu. Kombinacije tih lekova se takođe koriste za tretman sindroma nemirnih nogu.^[7]

Reference[uredi | uredi kod]

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ Shen H, Kannari K, Yamato H, Arai A, Matsunaga M (March 2003). „Effects of benserazide on L-DOPA-derived extracellular dopamine levels and aromatic L-amino acid decarboxylase activity in the striatum of 6-hydroxydopamine-lesioned rats”. The Tohoku journal of experimental medicine 199 (3): 149–59. DOI:10.1620/tjem.199.149. PMID 12703659.
↑ Ryan, Melody; Slevin, John T. (2006). "Restless legs syndrome". American Journal of Health-System Pharmacy. 63 (17): 1599-1612. Retrieved on 2008-02-06.

Spoljašnje veze[uredi | uredi kod]

	Portal Medicina
	Portal Hemija

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[4] Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

[5] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[pmid12703659-6] Shen H, Kannari K, Yamato H, Arai A, Matsunaga M (March 2003). „Effects of benserazide on L-DOPA-derived extracellular dopamine levels and aromatic L-amino acid decarboxylase activity in the striatum of 6-hydroxydopamine-lesioned rats”. The Tohoku journal of experimental medicine 199 (3): 149–59. DOI:10.1620/tjem.199.149. PMID 12703659.

[7] Ryan, Melody; Slevin, John T. (2006). "Restless legs syndrome". American Journal of Health-System Pharmacy. 63 (17): 1599-1612. Retrieved on 2008-02-06.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

Benserazid

Indikacije[uredi | uredi kod]

Reference[uredi | uredi kod]

Spoljašnje veze[uredi | uredi kod]

Navigacija

Pretraga